Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Thulin H [Influence of oral contraception upon the occurence of Candida albicans in the vagina]. 1971 Nord Med pmid:4995130
Jürgensen O et al. [Influence of norethisterone enanthate (SH 393) on ovarian function]. 1971 Acta Endocrinol Suppl (Copenh) pmid:5313575
Chinnatamby S A comparison of the long-acting contraceptive agents norethisterone oenanthate and medroxyprogesterone acetate. 1971 Aust N Z J Obstet Gynaecol pmid:5289724
Goldswain PR and Eales L The oral contraceptive norinyl-1 in porphyria. 1971 S. Afr. Med. J. pmid:5150263
Puigvert A and Mallo N [Progestational hormones in the treatment of reno-ureteral tuberculosis]. 1971 J Urol Nephrol (Paris) pmid:5155475
Schneider W [Changes of bleeding rhythm in normal biphasically menstruating women during continuing administration of small gestagen doses]. 1971 Z Geburtshilfe Gynakol pmid:5157078
Beckman L et al. Induction of the "pregnancy zone" protein by oral contraceptives. 1971 Acta Obstet Gynecol Scand pmid:5157502
Dohtel Y [Good results with Norethisterone in rheumatoid arthritis]. 1971 Acta Med Tenerife pmid:12306322
Böttiger LE and Westerholm B Oral contraceptives and thromboembolic disease. Swedish experience. 1971 Acta Med Scand pmid:5149274
Schmidt-Elmendorff H and Kaiser E [Influence of various oral contraceptives on hormone secretion of the hypophysis and ovary in the sexually mature female]. 1971 Arch Gynakol pmid:5108862
Tenhaeff D [Immunochemical determination of LH during therapy with oral and depot contraceptives]. 1971 Arch Gynakol pmid:4103780
Hormones in advanced cancer. 1971 Br Med J pmid:4253671
Gardner LI et al. Syndrome of multiple osseous defects with pretibial dimples. 1971 Lancet pmid:4104009
Elder MG et al. Plasma factor IX levels and oral contraception. 1971 J Obstet Gynaecol Br Commonw pmid:4104345
Farkas E and O'Toole DJ 17 alpha-ethynyl-17 beta-hydroxy-10 alpha-estr-4-en-3-one. 1971 Steroids pmid:5551842
Fuller ME Oral contraceptive therapy for differentiating ovarian cysts. 1971 Postgrad Med pmid:5557719
Cope E Management of abnormal bleeding. 1971 Br Med J pmid:5556066
Shevach AB and Spellacy WN Galactorrhea and contraceptive practices. 1971 Obstet Gynecol pmid:5560113
Glueck CJ et al. Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons. 1971 Ann. Intern. Med. pmid:5568147
Gamboa ET et al. Chorea associated with oral contraceptive therapy. 1971 Arch. Neurol. pmid:5571013
Morris NM and Udry JR Sexual frequency and contraceptive pills. 1971 Soc Biol pmid:4931720
Bell ET and Christie DW The use of progestagens in the control of the canine oestrous cycle. 1971 J Small Anim Pract pmid:4934624
Martin PL et al. Graded sequential therapy in the menopause: a double-blind study. 1971 Am. J. Obstet. Gynecol. pmid:4938602
Goldzieher JW et al. Nervousness and depression attributed to oral contraceptives: a double-blind, placebo-controlled study. 1971 Am. J. Obstet. Gynecol. pmid:4108553
Poller L et al. Oestrogen-progestogen oral contraception and blood clotting: a long-term follow-up. 1971 Br Med J pmid:5134560
Altchek A Dysfunctional menstrual disorders in adolescence. 1971 Clin Obstet Gynecol pmid:5146981
Rozenbaum H [A new oral contraceptive: LG 340]. 1971 Presse Med pmid:5093019
Board JA Continuous norethindrone, 0.35 mg., as an oral contraceptive agent. 1971 Am. J. Obstet. Gynecol. pmid:5100077
Revaz C et al. [Critical study of new contraceptive methods]. 1971 Schweiz Med Wochenschr pmid:5102692
Gillespie PJ et al. Possible clinical implications of therapeutically induced temperature changes in continuously monitored tumour mass. (Preliminary report). 1971 Br. J. Cancer pmid:5104072
Kesserü-Koos E Influence of various hormonal contraceptives on sperm migration in vivo. 1971 Fertil. Steril. pmid:5106268
Liang L and Fosgate OT Estrus synchronization and subsequent fertility in dairy cattle treated with 17-alpha-ethyl-19-nortestosterone (Nilevar) and 17-alpha-ethynyl-19-nortestosterone (SC4640). 1971 J. Anim. Sci. pmid:5106276
Proud AJ and Preece AW Measurement and treatment of mammary carcinoma in bitches. 1971 Vet. Rec. pmid:5107141
Holzmann H et al. [Treatment of scleroderma]. 1971 Jan-Feb Actas Dermosifiliogr pmid:5158422
de Sampaio Júnior LF et al. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic]. 1971 Jan-Mar Matern Infanc (Sao Paulo) pmid:5135370
Bernstein R Progestins as treatment in generalized progressive scleroderma. 1971 Jul-Aug J Oslo City Hosp pmid:5127433
de Virgiliis G and Staudacher C [Modifications of the pituitary gland after treatment with norethindrone-mestranol. An electron microscope study]. 1971 Jul-Aug Ann. Endocrinol. (Paris) pmid:5139432
Neme B et al. [0.35 mg of norethindrone in the control of human fertility]. 1971 Jul-Sep Matern Infanc (Sao Paulo) pmid:5152504
Zawidzka Z and Coldwell BB Effect of steroids, acetylsalicylic acid and bishydroxycoumarin on prothrombin time. 1971 May-Jun Eur J Toxicol pmid:4106764
Foote WD and Peterson DW Steroidal influence on morphology and behaviour in guinea-pigs. 1972 J. Reprod. Fertil. pmid:5073388
Beck RP et al. Thyroid function studies in different phases of the menstrual cycle and in women receiving norethindrone with and without estrogen. 1972 Am. J. Obstet. Gynecol. pmid:4110544
Kutner SJ and Brown WL Types of oral contraceptives, depression, and premenstrual symptoms. 1972 J. Nerv. Ment. Dis. pmid:4403361
Mink IB et al. Progestational agents and blood coagulation. IV. Changes induced by progestogen alone. 1972 Am. J. Obstet. Gynecol. pmid:4117904
Blood clotting and the pill. 1972 Br Med J pmid:4118011
Poller L et al. Effects of progestogen oral contraception with norethisterone on blood clotting and platelets. 1972 Br Med J pmid:4118012
Moghissi KS Morphologic changes in the ovaries of women treated with continuous microdose progestogens. 1972 Fertil. Steril. pmid:4651625
Tinsley FC and Brennan DM Antifertility effects of progestins in hamsters. 1972 Fertil. Steril. pmid:4118864
Poller L The effects of progestogens on blood clotting and platelet function. 1972 J. Clin. Pathol. pmid:4119307
Yokoyama Y Influences of gestagen upon carcinoma in situ of the cervix (a histologic study). 1972 Acta Obstet Gynaecol Jpn pmid:4119434
Müller R et al. [Comparative studies on endometrial behavior under the effect of various contraceptives]. 1972 Zentralbl Gynakol pmid:4119793
Chandra RK Serum levels of IgG and -macroglobulin and incidence of cryofibrinogenaemia in women taking oral contraceptives. 1972 J. Reprod. Fertil. pmid:4622500
Tenhaeff D et al. [Contraception with two low-dosage mestranol-norethisterone combinations]. 1972 Fortschr. Med. pmid:4641330
Cochrane P and Weatherall DJ The variation of neutrophil alkaline phosphatase during the menstrual cycle. 1972 J Obstet Gynaecol Br Commonw pmid:4642375
Larsson-Cohn U et al. Concentration of antithrombin 3 during combined and progestogen-only oral contraceptive treatment. 1972 Acta Obstet Gynecol Scand pmid:4642717
Schenker JG et al. The effect of oral contraceptives on microcirculation. 1972 Obstet Gynecol pmid:5049908
Briggs MH and Briggs M Preliminary studies on metabolic effects of a continuous-dose, progestogen-only, oral contraceptive. 1972 Afr J Med Sci pmid:5028467
Freudenthal RI et al. The whole body distribution of norethindrone, ethynodiol diacetate and progesterone in the pregnant mouse. 1972 J. Pharmacol. Exp. Ther. pmid:5048368
Oski FA et al. Reduced red cell filterability with oral contraceptive agents. 1972 Ann. Intern. Med. pmid:5053731
Kirby JF and Kraft GH Oral contraceptives and erythema nodosum. 1972 Obstet Gynecol pmid:5054972
Norrby A et al. The influence of a combined oral contraceptive on the absorption of iron. 1972 Scand J Haematol pmid:4626808
Kenyon IE Unplanned pregnancy in an epileptic. 1972 Br Med J pmid:5015305
Rose DP and Adams PW Oral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone. 1972 J. Clin. Pathol. pmid:5018716
Stephens ME et al. Oral contraceptives and folate metabolism. 1972 Clin Sci pmid:5020281
Martin PL et al. Oral menopausal therapy using 17- micronized estradiol. A preliminary study of effectiveness, tolerance and patient preference. 1972 Obstet Gynecol pmid:5023261
Fowler AK et al. Activation of C-type RNA virus markers in mouse uterine tissue. 1972 Proc. Natl. Acad. Sci. U.S.A. pmid:4340751
Gustafson A and Svanborg A Gonadal steroid effects on plasma lipoproteins and individual phospholipids. 1972 J. Clin. Endocrinol. Metab. pmid:4342037
Mishell DR et al. Serum estradiol in women ingesting combination oral contraceptive steroids. 1972 Am. J. Obstet. Gynecol. pmid:4645131
Kohorn EI et al. The relation of the structure of progestational steroids to nucleolar differentiation in human endometrium. 1972 J Clin Endocrinol pmid:12256658
Tobon H Malignant hypertension, uremia and hemolytic anemia in a patient on oral contraceptives. 1972 Obstet Gynecol pmid:5083217
Wilensky RJ and Hubbard TB Thrombosis of the digital vessels secondary to oral contraceptives. 1972 Am. J. Obstet. Gynecol. pmid:4635186
Nöldner H et al. [Experimental studies on estrus synchronization in sheep]. 1972 Arch Exp Veterinarmed pmid:4124867
Rau R et al. [Gestagen therapy of scleroderma. 10 cases]. 1972 Dtsch. Med. Wochenschr. pmid:5050239
Koetsavang A and Porapakkham S The effects of norethindrone on metropathic bleeding. 1972 J Med Assoc Thai pmid:5052583
Shroff AP and Shaw CJ In situ quantitation of norethindrone and mestranol by spectrodensitometry of thin layer chromatograms. 1972 J Chromatogr Sci pmid:5052968
Pelzmann KS and Havemeyer RN Concurrent water and drug absorption in the rat intestine. 1972 J Pharm Sci pmid:5058624
Vincent CK and Mills AC Gonadotropin levels for multiple births in beef cattle. 1972 J. Anim. Sci. pmid:5059176
Morcos F et al. The effect of norethindrone with and without estrogen on serum immunoreactive luteinizing hormone secretion. 1972 Am. J. Obstet. Gynecol. pmid:5060380
El Mahgoub S et al. Long term effects of injected progestogens on the morphology of human oviducts. 1972 J Reprod Med pmid:5063870
Robertson-Rintoul J Raised serum-lipids and oral contraceptives. 1972 Lancet pmid:4117855
Tarzy BJ et al. Rheumatic disease, abnormal serology, and oral contraceptives. 1972 Lancet pmid:4115567
Drill VA Oral contraceptives and thromboembolic disease. I. Prospective and retrospective studies. 1972 JAMA pmid:5066803
Turksoy RN Pituitary-adrenal responsiveness during microdose norethindrone therapy. 1972 Fertil. Steril. pmid:5008944
Johnson AL ( )-6,6-Difluoronorgestrel, a new synthetic hormonal steroid. 1972 J. Med. Chem. pmid:5019549
Meng M [Experiences with the "Minipill"]. 1972 Schweiz. Rundsch. Med. Prax. pmid:5021822
Maqueo M et al. Ovarian morphologyy after prolonged use of steroid contraceptive agents. 1972 Contraception pmid:4119577
Johnson AL Aliphatic esters of 6,6-difluoro-17 -hydroxy-17-ethynyl-4-estren-3-one (6,6-difluoronorethindrone) and (+)-6,6-difluoro-13 -ethyl-17 -hydroxy-17-ethynyl-4-gonen-3-one ((+)-6,6-difluoronorgestrel). 1972 Steroids pmid:5073576
Kishimoto Y et al. Metabolism of oral contraceptives. I. Metabolism of ethynodiol diacetate in women. 1972 Xenobiotica pmid:5076570
Hamner CE and Wilson LA Inhibition of capacitation in the rabbit. 1972 Fertil. Steril. pmid:4110310
Cook CE et al. Norethynodrel metabolites in human plasma and urine. 1972 J. Pharmacol. Exp. Ther. pmid:5080031
Kharma K et al. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol. 1972 Am. J. Obstet. Gynecol. pmid:4110418
Stillwell WG et al. Characterization of metabolites of steroid contraceptives by gas chromatography and mass spectrometry. 1972 J. Steroid Biochem. pmid:5085379
Rivers JM and Devine MM Plasma ascorbic acid concentrations and oral contraceptives. 1972 Am. J. Clin. Nutr. pmid:5035056
Johnson AL 17 -Propadienyl, 17 -propynyl, and 17 -trifluoropropynyl analogs of 6,6-difluoronorethindrone. 1972 J. Med. Chem. pmid:5044304
Yamazaki I and Nakayama R Comparison of ovulation-inducing effect between estrogen and progestin in the ovulation-blocked rat by chlorpromazine. 1972 Endocrinol. Jpn. pmid:4341647
Terenius L Specific progestogen binder in uterus of normal rats. 1972 Steroids pmid:4114433
Preston SN A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptives. 1972 Contraception pmid:4659582
Nygren KG et al. Postovulatory contraception in women with large doses of norethindrone. 1972 Contraception pmid:4650660
Levine LS et al. Androgen production in boys with sexual precocity and congenital adrenal hyperplasia. 1972 Metab. Clin. Exp. pmid:4335735
Lawson JP and Bradshaw FR Experience with norethisterone 0.35 mg. as an oral contraceptive--a preliminary report. 1972 Curr Med Res Opin pmid:4668861
Larsson-Cohn U et al. Effects of continuous daily administration of 0.1 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens. 1972 Acta Endocrinol. pmid:4678199